about
Centrosome overduplication and mitotic instability in PKD2 transgenic linesEndothelin Blockade in Diabetic Kidney DiseaseValue of plasmatic membrane attack complex as a marker of severity in acute kidney injuryRole of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study.Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease.Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse.Characterization of ACE and ACE2 Expression within Different Organs of the NOD MouseNew options and perspectives for proteinuria management after kidney transplantation.Renin-angiotensin system within the diabetic podocyte.RAS and sex differences in diabetic nephropathy.Circulating Ace2 in Cardiovascular and Kidney DiseasesThe enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response.Promising effects of ischemic preconditioning in renal transplantation.Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats.Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress.High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin.Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.Albumin inhibits the insulin-mediated ACE2 increase in cultured podocytes.Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin-angiotensin system.Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease.Correction: Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse.ACE2 and ACE in acute and chronic rejection after human heart transplantationMembrane Attack Complex and Factor H in Humans with Acute Kidney InjuryTubular Epithelial Cells Transfected With hHGF Counteracts Monocyte Chemotactic Protein-1 Up-regulation After Hypoxia/Reoxygenation InsultROLE OF PAF AND OXIDANT AGENTS ON VASCULAR CELL PROLIFERATION. IN VITRO IMPLICATION OF MTOR-DEPENDENT PATHWAYCirculating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patientsSex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathyCirculating Angiotensin-Converting Enzyme 2 Activity in Kidney Transplantation: A Longitudinal Pilot StudyOverexpression of complement-component genes in Han:SPRD rats a model of polycystic kidney diseaseTranscriptome analysis of a rat PKD model: Importance of genes involved in extracellular matrix metabolismIntramuscular SP1017-formulated DNA electrotransfer enhances transgene expression and distributes hHGF to different rat tissuesThe ether phospholipids trail: blood timing in renal ischemia-reperfusion injuryLong-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized ratsEffect of ETA/ETB receptor antagonist administration on iNOS gene expression in a rat renal transplantation modelIschemic preconditioning improves postischemic acute renal failureEffect of Human Natural Xenoantibody Depletion and Complement Inactivation on Early Pig Kidney FunctionFunctional and pathologic outcome after complement inactivation in a pig kidney-human blood xenoperfusion modelChanges in renal hemodynamics and physiology after normothermic ischemia in animals supplemented with eicosapentaenoic acid
P50
Q24336465-1AEE8D90-F1B4-48BB-82D9-80FB23169657Q26799476-A859D1DC-11A7-40A3-B309-99CA30E7B70CQ33747949-2FE05B11-AE9E-4760-ADB5-229E154AE4E4Q34695637-99E8EC56-85D5-49BD-86A1-3A8A7BA5B109Q35588005-9C735A2B-CC23-4203-9FD9-3C77FE2D22AAQ36243548-00496755-D4D0-45F5-A0CF-8E870A6824B5Q37439317-C64872F2-3A3B-4A72-9E20-9BAE23F44673Q37729150-9CEB542F-A76F-4856-9069-94B6C6B46978Q37964276-95CE9F2D-B3D3-4372-A43F-33E33146B51BQ38262105-2D26EA46-533A-4FDA-A0EB-B5E0930D01E1Q38768074-5F5FEE65-51E5-49D4-8E73-A3230455ADEBQ39245714-7B54039F-F2CB-4AA0-ABA6-967D3945A5E7Q43768131-3EFBD803-7C0D-4C0B-A8FF-22BD1C817616Q44004854-2BFD7B4A-12DD-4236-81F3-3ABFD3E3E619Q45874042-FB41C3C7-9941-4137-8A28-9A6C7CD926C8Q46068693-D208A40B-E0C8-4723-AD3D-E50C015F51F5Q46160285-27A09A67-E2FA-48DB-A438-4CFEC3DAFCA9Q47712226-76777262-5D46-49BC-8ABE-56D9D3395F07Q50433834-9EC0A467-84E2-4F22-B785-7493E8F7797BQ50475761-E04F5C31-FC9E-414B-B270-9E1BCE2EAF15Q51662702-A2FFC06B-5677-4092-950F-7986AC6B5C3DQ54511982-01D76B4B-5CD8-4FB7-9835-EBCE89FF11A4Q55646105-C13A83D3-B8A9-42CE-87A8-33FF1CCF6186Q57484538-96973A1D-A9FB-4122-8BA2-52DEC1CEE69BQ58089739-D02A1046-9A51-4EEF-BE90-CD0B5D19F19FQ59491281-3B8917B6-3259-489D-B690-3868CABC9EFEQ59491292-59976396-AA5F-4F6E-98D0-62001B0295F7Q60484089-87D25FCB-AADC-4CD4-8ED5-BA5DDF35C61AQ60484091-9044DF53-F68E-46B2-A76B-A301F89CE9EAQ60484102-ED120D5A-979D-4CEA-89A2-C48644CE02ABQ60484103-F423DF5A-EA15-4371-A213-6211276AFDB8Q60484105-BB7F5C5B-B568-442C-904E-100D3044477CQ60484109-95052C21-B5CD-4ED3-874A-190DAC5461CFQ60484114-37739159-7980-4F3D-99DB-2C87CA2AC2A4Q60484120-6F7B7056-7F31-4D31-9CEB-69AD6E75DAF1Q60484123-28127791-E750-47FF-8A9D-C2024769D8EFQ60484124-469AFBAD-5CAB-43DA-A8A8-898FB2245D62Q60484127-B7598BE7-744A-4359-93F2-DE59292988BEQ60484131-85D759D5-45DF-4E92-88C2-A98DE3697E8DQ60484136-2F69F54A-5B86-4932-9F23-D0A8EAD709E6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marta Riera
@ast
Marta Riera
@en
Marta Riera
@es
Marta Riera
@nl
Marta Riera
@sl
type
label
Marta Riera
@ast
Marta Riera
@en
Marta Riera
@es
Marta Riera
@nl
Marta Riera
@sl
altLabel
Marta Riera Oliva
@en
prefLabel
Marta Riera
@ast
Marta Riera
@en
Marta Riera
@es
Marta Riera
@nl
Marta Riera
@sl
P108
P1053
V-5016-2017
P106
P108
P21
P31
P3829
P496
0000-0003-4362-7965